Researchers have developed the first blood test that can accurately detect more than 50 types of cancer and identify in which tissue the cancer originated, often before there are any clinical signs or symptoms of the disease.
A growth hormone called IGF-1 is likely to play a role in the development of breast cancer, according to new research published in Annals of Oncology.
International Women’s Day: ESMO supports women in South Africa to become autonomous workers.
In view of the spread of Coronavirus infections across Europe and now increasingly in France, ESMO has made the difficult but necessary decision not to proceed with the TAT Congress, due to take place 2-4 March in Paris.
For enquiries please contact us on media@esmo.org
Due to the current situation with the Covid-19 infection, it is not possible to proceed with the ESMO Breast Cancer Congress in its original format.
In due consideration of the latest information on the Coronavirus outbreak, ESMO and IASLC have made the unavoidable decision to cancel the ELCC 2020 Congress, due to take place 15-18 April in Geneva, Switzerland.
TMB is actively being studied as a predictive biomarker for identifying patients who might benefit from immunotherapy but the issue of variability between assays has been raised
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.
